ERK/MAP Kinase Activation is Evident in Activated Microglia of the Striatum and Substantia Nigra in an Acute and Chronically-Induced Mouse Model of Parkinson’s Disease-Reference-Cited by-同舟云学术

ERK/MAP Kinase Activation is Evident in Activated Microglia of the Striatum and Substantia Nigra in an Acute and Chronically-Induced Mouse Model of Parkinson’s Disease

Published:2019-01-18 Issue:4 Volume:15 Page:336-344
ISSN:1567-2026
Container-title:Current Neurovascular Research
language:en
Short-container-title:CNR

Author:

Sarkar Sumit¹,Lu Edward²,Raymick James¹,Hanig Joseph³,Gu Qiang¹

Affiliation:

1. Division of Neurotoxicology National Center for Toxicological Research (NCTR), FDA, White Oak, MD-20993, United States

2. University of New Mexico School of Medicine, Albuquerque, NM 87106, United States

3. Office of Testing & Research, Center for Drug Evaluation Research (CDER), White Oak, MD-20993, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Cellular and Molecular Neuroscience,Developmental Neuroscience,Neurology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the AKT/ERK cascade and its role in Parkinson disease;Archives of Toxicology;2024-08-13

2. Oncogenic BRAF^V600E induces microglial proliferation through extracellular signal-regulated kinase and neuronal death through c-Jun N-terminal kinase;Neural Regeneration Research;2023

3. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks;Pharmacological Research;2021-08

4. Map kinase signaling as therapeutic target for neurodegeneration;Pharmacological Research;2020-10

5. Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein;Journal of Neuroinflammation;2020-09-17